Next, we investigated the effect of the declined PRMT1 expression in ECs on COPD phenotype using tamoxifen‐inducible endothelial PRMT1 heterozygous KO mice (Prmt1fl/+; Cdh5ERT2–Cre). Here, PRMT1 is linked to chronic obstructive pulmonary disease.